Article
Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
Pediatric rheumatology online journal - 1 Jan 2015
van Dijkhuizen Evert Hendrik Pieter, Bulatović Ćalasan Maja, Pluijm Saskia M F, de Rotte Maurits C F J, Vastert Sebastiaan J, Kamphuis Sylvia, de Jonge Robert, Wulffraat Nico M
Abstract excerpt
BACKGROUND: Methotrexate (MTX) is an effective and safe drug in the treatment of juvenile idiopathic arthritis (JIA). Despite its safety, MTX-related gastrointestinal adverse effects before and after MTX administration, termed MTX intolerance, occur frequently, leading to non-compliance and potentially premature MTX termination. The aim of this study was to construct a risk model to predict MTX intolerance....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
